European Equities Traded in the US as American Depositary Receipts Lower in Wednesday Trading

European equities traded in the US as American depositary receipts were trending lower late Wednesday morning, declining 0.49% to 1,307.19 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biopharmaceutical companies DBV Technologies (DBVT) and Genfit (GNFT), which rose 5.3% and 4.8% respectively. They were followed by pharmaceutical company Novo Nordisk (NVO) and biopharmaceutical company argenx (ARGX), which were up 2.2% and 1.9% respectively.

The decliners from continental Europe were led by biopharmaceutical company Cellectis (CLLS) and semiconductor company Sequans Communications (SQNS), which fell 7.9% and 5.2% respectively. They were followed by biotech firm Evaxion Biotech (EVAX) and biopharmaceutical company Grifols (GRFS), which dropped 2.8% and 2.4% respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical company Amarin (AMRN) and cruise line operator Carnival (CUK), which increased 2.7% and 0.6% respectively. They were followed by financial services company HSBC (HSBC) and mining company BHP Group (BHP), which were up 0.5% and 0.3% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical companies Adaptimmune Therapeutics (ADAP) and TC Biopharm (TCBP), which shed 8.3% and 7.6% respectively. They were followed by biotech firm Trinity Biotech plc (TRIB) and biopharmaceutical company NuCana (NCNA), which lost 6.8% and 5.7% respectively.